Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRAF inhibition in refractory hairy-cell leukemia.

The New England journal of medicine - 24 May 2012

Dietrich Sascha, Glimm Hanno, Andrulis Mindaugas, von Kalle Christof, Ho Anthony D, Zenz Thorsten

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Vemurafenib
Share to Antineoplastic Agents
Share to Indoles
Share to Leukemia, Hairy Cell

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Share to Remission Induction

Share to Sulfonamides

Source

Identifiers

PMID: 22621641
DOI: 10.1056/NEJMc1202124

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRAF inhibition in refractory hairy-cell leukemia.PMID 22621641Read ↗

BRAF inhibitor treatment in classic hairy cell leukemia: a long-term follow-up study of patients treated outside clinical trials.Semantic proximity Read ↗

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia.Semantic proximity Read ↗

Efficacy of vemurafenib in hairy-cell leukemia.Semantic proximity Read ↗

Targetable Mutations in BRAF V600E–Negative Hairy-Cell LeukemiaSemantic proximity Read ↗

[Molecular and therapeutic advances in Hairy cell leukemia].Semantic proximity Read ↗

Non-V600E BRAF mutations and treatment for hairy cell leukemia.Semantic proximity Read ↗

Rapid response to vemurafenib in a heavily pretreated patient with hairy cell leukemia and a BRAF mutation.Semantic proximity Read ↗

Hairy cell leukemia: Past, present and future.Semantic proximity Read ↗

Treatment of refractory hairy cell leukemia with a BRAF-inhibitor: lessons to be learnt.Semantic proximity Read ↗

BRAF mutation in hairy cell leukemiaSemantic proximity Read ↗

BRAF V600E mutation in hairy cell leukemia: from bench to bedsideSemantic proximity Read ↗

Hairy cell leukemia: update and current therapeutic approach.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.